Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.67 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.67 |
| ▸ | ANPEP | P15144 | 1/20 | 0.64 |
| ▸ | DPP4 | P27487 | 2/20 | 0.62 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.59 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10821457 | 1.00 | DPP8 (0.67) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL6356988 | 1.00 | DPP8 (0.67) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL6356943 | 0.99 | DPP8 (0.65) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL5189156 | 0.99 | DPP8 (0.65) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL3132219 | 0.99 | DPP8 (0.65) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL1586583 | 0.96 | DPP8 (0.61) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL12619410 | 0.96 | DPP8 (0.61) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL1586581 | 0.96 | DPP8 (0.61) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL28567293 | 0.95 | DPP8 (0.60) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL6624995 | 0.95 | DPP8 (0.60) | DPP8DPP7ANPEPDPP4DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315957-B | Preparation method of polypeptide | 深圳瑞德林生物技术有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-114315957-A | Preparation method of polypeptide | 深圳瑞德林生物技术有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-20240238422-A1 | Hypoimmunogenic Biotherapeutics | ADAXION THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |
| WO-2024094098-A1 | COMPOUND FOR DELIVERY SYSTEM AND USE THEREOF | 益杰立科(上海)生物科技有限公司 | 2024-05-10 | — | — | WO | disclosed |
| CN-114315957-B | Preparation method of polypeptide | 深圳瑞德林生物技术有限公司 | 2023-07-07 | — | — | CN | disclosed |
| US-20230210110-A1 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | AJINOMOTO CO., INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20230210110-A1 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | AJINOMOTO CO., INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| EP-3988561-B1 | PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER | XWPHARMA LTD (KY) | 2023-06-07 | — | — | EP | disclosed |
| EP-3988561-A1 | PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER | XWPharma Ltd. (KY) | 2022-04-27 | — | — | EP | disclosed |
| US-11312703-B2 | Reactive oxygen species scavengers and use for treating diseases | XWPharma Ltd. (KY) | 2022-04-26 | — | — | US | disclosed |
| EP-3980052-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2022-04-13 | — | — | EP | disclosed |
| EP-1263716-A2 | AMINO ACID DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS | Pharmacor Inc. (CA) | 2002-12-11 | — | — | EP | disclosed |
| US-6455587-B1 | AROMATIC SULFONYL DERIVATIVES | PHARMACOR INC. (CA) | 2002-09-24 | — | — | US | disclosed |
| WO-2001068593-A2 | AMINO ACID DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS | PHARMACOR INC. (CA) | 2001-09-20 | — | — | WO | disclosed |
| US-5494898-A | DIQUATERNARY TRIPEPTIDES | OHMEDA PHARMACEUTICAL PRODUCTS DIVISION INC. (US) | 1996-02-27 | — | — | US | disclosed |
| US-H1312-H | Method for the preparation of gyk-dtpa | CYTOGEN CORPORATION (US) | 1994-05-03 | — | — | US | disclosed |
| EP-0313969-B1 | TRIPEPTIDE DERIVATIVES AND ANTIPLASMIN AGENTS CONTAINING THE SAME | NITTO BOSEKI CO., LTD. (JP) | 1993-03-24 | — | — | EP | disclosed |
| EP-0498941-A2 | Peptide skeletal muscle relaxants | BOC Health Care, Inc. (US) | 1992-08-19 | — | — | EP | disclosed |
| US-4883863-A | FROM LYSINE OR TYROSINE, PHENYLALANINE AND LYSINE, HEMOSTATIC AGENTS | NITTO BOSEKI CO., LTD. (JP) | 1989-11-28 | — | — | US | disclosed |
| EP-0313969-A2 | Tripeptide derivatives and antiplasmin agents containing the same | NITTO BOSEKI CO., LTD. (JP) | 1989-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230210110-A1 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | DAO, ALAD, BCAT1 | DPP8 1787/4885DPP7 2381/4885ANPEP 51/4885 |
| US-11312703-B2 | Reactive oxygen species scavengers and use for treating diseases | GSR, TXNRD2, GPX1 | DPP8 3553/4885DPP7 3005/4885ANPEP 3786/4885 |
| US-20240238422-A1 | Hypoimmunogenic Biotherapeutics | FCGR3B, CD47, IL2 | DPP8 2388/4885DPP7 1836/4885ANPEP 2185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.